A Multi-center, Prospective, Observational Study to Describe the siTuation

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05565742` - A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)]	Phase 2
Completed	`NCT05563246` - A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events	Phase 2
Recruiting	`NCT04156997` - Extreme Lipids Repository
Recruiting	`NCT05496790` - Role of LipoprotEin(a) in CardiovascuLar Diseases and Premature Acute Coronary Syndromes - (RELACS) Study

See also

Status

Clinical Trial

Phase

Active, not recruiting

NCT05565742 - A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)]

Phase 2

Completed

NCT05563246 - A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

Phase 2

Recruiting

NCT04156997 - Extreme Lipids Repository

Recruiting

NCT05496790 - Role of LipoprotEin(a) in CardiovascuLar Diseases and Premature Acute Coronary Syndromes - (RELACS) Study

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05081440
Study type	Observational
Source	Huashan Hospital
Contact	yong li
Phone	+86 13801753494
Email	liyong606@126.com
Status	Not yet recruiting
Phase
Start date	December 1, 2021
Completion date	December 1, 2022

A Multi-center, Prospective, Observational Study to Describe the siTuation of Blood Lipid mAnagement Among the Population With hypeRtension and/or Type 2 diabeTes in Community Health Center

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms